Skip to main content

Anthony Cerami Award in Translational Medicine


Molecular Medicine has established the Anthony Cerami Award in Translational Medicine to honor investigators who have created the fundamental innovation necessary for molecular medicine to advance into clinical practice.  The award recognizes leading edge discoveries that have led to improvement of human health, and have opened the door to new therapeutic advances and understanding.

Recipients are investigators who provided the crucial early insight and ideas that are the essence of discovery, creating new fields and research trajectories followed by the persistent clinical investigation that ultimately changes how disease is prevented, diagnosed, and treated. The award celebrates and commemorates the unique attributes of insight, genius, and perseverance that are at the heart of the discovery process.

The recipient receives a $20,000 USD award, and is invited to publish a monograph of their work that inspired or produced the clinical product(s). The monograph represents a unique opportunity to capture the inspirations, insights, surprises, and conceptual advances that are woven into the history of these discoveries, but if left untold, may be lost from the permanent record.

True innovators in medicine and health care are rare, and their stories even more precious.  The Anthony Cerami Award monographs will provide sources of inspiration and insight to subsequent generations, by providing the stories behind the pioneering advances.  The monographs will be written in the first person as an account of the personal experience behind the scientific research. As described in a narrative format, these articles will provide insight into the driving forces that were at work, the decision points, the scientific/political/social climate, and the key results that changed the future.

Monographs, in the voice of the discoverer, will permanently document their stories and inspire future innovators to advance medicine.

The Anthony Cerami Award in Translational Medicine - an Editorial by Kevin J Tracey, MD

Read more here.

Cerami Award winner 2019

A Journey in Science: Immersion in the search for effective cancer immunotherapies

The eighth Anthony Cerami Award in Translational Medicine was awarded to Steven A. Rosenberg, MD, PhD, Chief of Surgery at the National Cancer Institute in Bethesda, Maryland, USA. The award is in recognition of his pioneering research in the development of immunotherapies and gene therapies for advanced cancers.

In his monograph, Dr. Rosenberg writes about how his research in the field of effective cancer immunotherapies included groundbreaking work such as the discovery of IL-2 administration, cell transfer immunotherapy, and gene therapy as approved human cancer immunotherapies.

“It  is an honor to join the distinguished group of prior winners of this prestigious Anthony Cerami award in Translational Medicine. This award provided me with the stimulus to reflect upon the past four decades of my work attempting to develop effective immunotherapies for patients with cancer using naturally occurring or genetically modified lymphocytes as a “living drug” for cancer treatment." 

Past winners

Cerami Award 2017

Cerami Award 2016

Cerami Award 2015

Cerami Award 2014

Cerami Award 2013

Annual Journal Metrics

  • Speed
    43 days to first decision for reviewed manuscripts only
    28 days to first decision for all manuscripts
    128 days from submission to acceptance
    24 days from acceptance to publication

    Citation Impact
    6.354 - 2-year Impact Factor
    5.230 - 5-year Impact Factor

    204 Altmetric mentions